Tacrine Treatment of Alzheimer’s Disease: Many Expectations,Few Certainties

Publisher： Karger

E-ISSN： 1423-0224|38|4|226-231

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.38, Iss.4, 1998-11, pp. : 226-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Acute Nicotine Administration on Cognitive Event-Related Potentials in Tacrine-Treated and Non-Treated Patients with Alzheimer’s Disease

By  

Neuropsychobiology, Vol. 45, Iss. 3, 2002-04 ,pp. : 156-160

Karger

Access to resources Recommend Favorite

Altered Verbal Working Memory Process in Patients with Alzheimer’s Disease

By  

Neuropsychobiology, Vol. 57, Iss. 4, 2008-07 ,pp. : 181-187

Karger

Access to resources Recommend Favorite

Influence of Anticholinergic Activity in Serum on Clinical Symptoms of Alzheimer’s Disease

By  

Neuropsychobiology, Vol. 63, Iss. 3, 2011-01 ,pp. : 147-153

Karger

Access to resources Recommend Favorite

EEG Alterations in Subjects at High Familial Risk for Alzheimer’s Disease

By  

Neuropsychobiology, Vol. 48, Iss. 3, 2003-11 ,pp. : 152-159

Karger

Access to resources Recommend Favorite

No Association between Alpha-1-Antichymotrypsin Polymorphism and Alzheimer’s Disease in Chinese

By  

Neuropsychobiology, Vol. 40, Iss. 2, 1999-08 ,pp. : 67-70

Karger

Access to resources Recommend Favorite